North America Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025

List of Tables

The North America Computational Pathology Market would witness market growth of 7.4% CAGR during the forecast period (2025-2032).

The US market dominated the North America Computational Pathology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $321.3 million by 2032. The Canada market is experiencing a CAGR of 9.6% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 8.6% during (2025 - 2032).

This market is rapidly emerging as a transformative force in the medical and healthcare sectors, potentially revolutionizing how pathologists diagnose diseases and provide patient care. It integrates advanced technologies such as Artificial Intelligence (AI), Machine Learning (ML), and data analytics with traditional pathology practices to analyze medical data more accurately, efficiently, and in a way that enhances diagnostic capabilities.

The market is growing rapidly, driven by an increasing demand for precise diagnostics, personalized medicine, and more efficient workflows in laboratories and hospitals. Computational pathology, which uses computational algorithms to analyze pathology data, has many applications in clinical diagnostics, research, and personalized medicine. One key application is the automated analysis of digital pathology slides.

Canada's government has pledged $198.6 billion over ten years to strengthen healthcare services, including $46.2 billion in new funding for provinces and territories. This investment aims to modernize healthcare infrastructure, reduce diagnostic delays, and enhance access to advanced technologies. These pathology stands to benefit significantly from this push, particularly in cancer care, pathology labs, and Indigenous health initiatives. As Canada focuses on improving early diagnosis and equitable healthcare delivery, the demand for scalable, AI-enabled diagnostic solutions like computational pathology is expected to rise considerably. In Mexico, cancer has become the third leading cause of death, with more than 195,000 new cases reported in 2020 alone. Breast, prostate, thyroid, colon, and cervical cancers are among the most prevalent, creating an urgent need for accurate and timely diagnosis. Computational pathology, with its ability to provide high-resolution digital imaging and AI-assisted tissue analysis, offers a powerful solution to Mexico's growing cancer burden. In summary, the increasing healthcare investments in Canada, the rising cancer burden in Mexico, and the high per capita U.S. spending collectively drive substantial growth in the market across North America.

Based on Component, the market is segmented into Software and Services. Based on Application, the market is segmented into Disease Diagnosis, Drug Discovery & Development, and Academic Research. Based on End-use, the market is segmented into Hospitals and Diagnostic Labs, Biotechnology & Pharmaceutical Companies, Academic and Research Institutes, and Other End-use. Based on Technology, the market is segmented into Machine Learning (ML), (Deep Learning and Other Machine Learning (ML)), Computer Vision, Natural Language Processing (NLP) Models, and Other Technology. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
PathAI, Inc.
Hamamatsu Photonics K.K.
Olympus Corporation
Visiopharm A/S
Mikroscan Technologies, Inc.
MindPeak GmbH
Indica Labs, LLC
Nucleai, Inc. (Nucleai)

North America Computational Pathology Market Report Segmentation

By Component

Software
Services

By Application

Disease Diagnosis
Drug Discovery & Development
Academic Research

By End-use

Hospitals and Diagnostic Labs
Biotechnology & Pharmaceutical Companies
Academic and Research Institutes
Other End-use

By Technology

Machine Learning (ML)
- Deep Learning
- Other Machine Learning (ML)
Computer Vision
Natural Language Processing (NLP) Models
Other Technology

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Computational Pathology Market, by Component
- 1.4.2 North America Computational Pathology Market, by Application
- 1.4.3 North America Computational Pathology Market, by End-use
- 1.4.4 North America Computational Pathology Market, by Technology
- 1.4.5 North America Computational Pathology Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. North America Computational Pathology Market by Component

5.1 North America Software Market by Region
5.2 North America Services Market by Region

Chapter 6. North America Computational Pathology Market by Application

6.1 North America Disease Diagnosis Market by Country
6.2 North America Drug Discovery & Development Market by Country
6.3 North America Academic Research Market by Country

Chapter 7. North America Computational Pathology Market by End-use

7.1 North America Hospitals and Diagnostic Labs Market by Country
7.2 North America Biotechnology & Pharmaceutical Companies Market by Country
7.3 North America Academic and Research Institutes Market by Country
7.4 North America Other End-use Market by Country

Chapter 8. North America Computational Pathology Market by Technology

8.1 North America Machine Learning (ML) Market by Country
8.2 North America Computational Pathology Market by Machine Learning (ML) Type
- 8.2.1 North America Deep Learning Market by Country
- 8.2.2 North America Other Machine Learning (ML) Market by Country
8.3 North America Computer Vision Market by Country
8.4 North America Natural Language Processing (NLP) Models Market by Country
8.5 North America Other Technology Market by Country

Chapter 9. North America Computational Pathology Market by Country

9.1 US Computational Pathology Market
- 9.1.1 US Computational Pathology Market by Component
- 9.1.2 US Computational Pathology Market by Application
- 9.1.3 US Computational Pathology Market by End-use
- 9.1.4 US Computational Pathology Market by Technology
  - 9.1.4.1 US Computational Pathology Market by Machine Learning (ML) Type
9.2 Canada Computational Pathology Market
- 9.2.1 Canada Computational Pathology Market by Component
- 9.2.2 Canada Computational Pathology Market by Application
- 9.2.3 Canada Computational Pathology Market by End-use
- 9.2.4 Canada Computational Pathology Market by Technology
  - 9.2.4.1 Canada Computational Pathology Market by Machine Learning (ML) Type
9.3 Mexico Computational Pathology Market
- 9.3.1 Mexico Computational Pathology Market by Component
- 9.3.2 Mexico Computational Pathology Market by Application
- 9.3.3 Mexico Computational Pathology Market by End-use
- 9.3.4 Mexico Computational Pathology Market by Technology
  - 9.3.4.1 Mexico Computational Pathology Market by Machine Learning (ML) Type
9.4 Rest of North America Computational Pathology Market
- 9.4.1 Rest of North America Computational Pathology Market by Component
- 9.4.2 Rest of North America Computational Pathology Market by Application
- 9.4.3 Rest of North America Computational Pathology Market by End-use
- 9.4.4 Rest of North America Computational Pathology Market by Technology
  - 9.4.4.1 Rest of North America Computational Pathology Market by Machine Learning (ML) Type

Chapter 10. Company Profiles

10.1 Koninklijke Philips N.V.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
  - 10.1.5.1 Partnerships, Collaborations, and Agreements:
- 10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Partnerships, Collaborations, and Agreements:
  - 10.2.5.2 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
10.3 PathAI, Inc.
- 10.3.1 Company Overview
- 10.3.2 Recent strategies and developments:
  - 10.3.2.1 Partnerships, Collaborations, and Agreements:
  - 10.3.2.2 Product Launches and Product Expansions:
- 10.3.3 SWOT Analysis
10.4 Hamamatsu Photonics K.K.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 SWOT Analysis
10.5 Olympus Corporation
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 SWOT Analysis
10.6 Visiopharm A/S
- 10.6.1 Company Overview
- 10.6.2 Recent strategies and developments:
  - 10.6.2.1 Partnerships, Collaborations, and Agreements:
  - 10.6.2.2 Product Launches and Product Expansions:
- 10.6.3 SWOT Analysis
10.7 Mikroscan Technologies, Inc.
- 10.7.1 Company Overview
10.8 MindPeak GmbH
- 10.8.1 Company Overview
- 10.8.2 Recent strategies and developments:
  - 10.8.2.1 Partnerships, Collaborations, and Agreements:
10.9 Indica Labs, Inc.
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
  - 10.9.2.1 Partnerships, Collaborations, and Agreements:
- 10.9.3 SWOT Analysis
10.10. Nucleai, Inc. (Nucleai)
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
  - 10.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

TABLE 1 North America Computational Pathology Market, 2021 - 2024, USD Million
TABLE 2 North America Computational Pathology Market, 2025 - 2032, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Computational Pathology Market
TABLE 4 Product Launches And Product Expansions- Computational Pathology Market
TABLE 5 North America Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 6 North America Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 7 North America Software Market by Region, 2021 - 2024, USD Million
TABLE 8 North America Software Market by Region, 2025 - 2032, USD Million
TABLE 9 North America Services Market by Region, 2021 - 2024, USD Million
TABLE 10 North America Services Market by Region, 2025 - 2032, USD Million
TABLE 11 North America Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 12 North America Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 13 North America Disease Diagnosis Market by Country, 2021 - 2024, USD Million
TABLE 14 North America Disease Diagnosis Market by Country, 2025 - 2032, USD Million
TABLE 15 North America Drug Discovery & Development Market by Country, 2021 - 2024, USD Million
TABLE 16 North America Drug Discovery & Development Market by Country, 2025 - 2032, USD Million
TABLE 17 North America Academic Research Market by Country, 2021 - 2024, USD Million
TABLE 18 North America Academic Research Market by Country, 2025 - 2032, USD Million
TABLE 19 North America Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 20 North America Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 21 North America Hospitals and Diagnostic Labs Market by Country, 2021 - 2024, USD Million
TABLE 22 North America Hospitals and Diagnostic Labs Market by Country, 2025 - 2032, USD Million
TABLE 23 North America Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2024, USD Million
TABLE 24 North America Biotechnology & Pharmaceutical Companies Market by Country, 2025 - 2032, USD Million
TABLE 25 North America Academic and Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 26 North America Academic and Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 27 North America Other End-use Market by Country, 2021 - 2024, USD Million
TABLE 28 North America Other End-use Market by Country, 2025 - 2032, USD Million
TABLE 29 North America Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 30 North America Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 31 North America Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
TABLE 32 North America Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
TABLE 33 North America Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 34 North America Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 35 North America Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 36 North America Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 37 North America Other Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
TABLE 38 North America Other Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
TABLE 39 North America Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 40 North America Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 41 North America Natural Language Processing (NLP) Models Market by Country, 2021 - 2024, USD Million
TABLE 42 North America Natural Language Processing (NLP) Models Market by Country, 2025 - 2032, USD Million
TABLE 43 North America Other Technology Market by Country, 2021 - 2024, USD Million
TABLE 44 North America Other Technology Market by Country, 2025 - 2032, USD Million
TABLE 45 North America Computational Pathology Market by Country, 2021 - 2024, USD Million
TABLE 46 North America Computational Pathology Market by Country, 2025 - 2032, USD Million
TABLE 47 US Computational Pathology Market, 2021 - 2024, USD Million
TABLE 48 US Computational Pathology Market, 2025 - 2032, USD Million
TABLE 49 US Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 50 US Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 51 US Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 52 US Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 53 US Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 54 US Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 55 US Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 56 US Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 57 US Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 58 US Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 59 Canada Computational Pathology Market, 2021 - 2024, USD Million
TABLE 60 Canada Computational Pathology Market, 2025 - 2032, USD Million
TABLE 61 Canada Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 62 Canada Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 63 Canada Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 64 Canada Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 65 Canada Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 66 Canada Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 67 Canada Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 68 Canada Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 69 Canada Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 70 Canada Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 71 Mexico Computational Pathology Market, 2021 - 2024, USD Million
TABLE 72 Mexico Computational Pathology Market, 2025 - 2032, USD Million
TABLE 73 Mexico Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 74 Mexico Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 75 Mexico Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 76 Mexico Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 77 Mexico Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 78 Mexico Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 79 Mexico Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 80 Mexico Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 81 Mexico Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 82 Mexico Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 83 Rest of North America Computational Pathology Market, 2021 - 2024, USD Million
TABLE 84 Rest of North America Computational Pathology Market, 2025 - 2032, USD Million
TABLE 85 Rest of North America Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 86 Rest of North America Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 87 Rest of North America Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 88 Rest of North America Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 89 Rest of North America Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 90 Rest of North America Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 91 Rest of North America Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 92 Rest of North America Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 93 Rest of North America Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 94 Rest of North America Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 95 Key Information - Koninklijke Philips N.V.
TABLE 96 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 97 Key Information - PathAI, Inc.
TABLE 98 key information - Hamamatsu Photonics K.K.
TABLE 99 Key Information - Olympus Corporation
TABLE 100 Key Information - Visiopharm A/S
TABLE 101 Key Information - Mikroscan Technologies, Inc.
TABLE 102 Key Information - MindPeak GmbH
TABLE 103 Key Information - Indica Labs, Inc.
TABLE 104 Key Information - Nucleai, Inc.

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 North America Computational Pathology Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Computational Pathology Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2024
FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
FIG 7 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
FIG 8 Porter's Five Forces Analysis - Computational Pathology Market
FIG 9 North America Computational Pathology Market share by Component, 2024
FIG 10 North America Computational Pathology Market share by Component, 2032
FIG 11 North America Computational Pathology Market by Component, 2021 - 2032, USD Million
FIG 12 North America Computational Pathology Market share by Application, 2024
FIG 13 North America Computational Pathology Market share by Application, 2032
FIG 14 North America Computational Pathology Market by Application, 2021 - 2032, USD Million
FIG 15 North America Computational Pathology Market share by End-use, 2024
FIG 16 North America Computational Pathology Market share by End-use, 2032
FIG 17 North America Computational Pathology Market by End-use, 2021 - 2032, USD Million
FIG 18 North America Computational Pathology Market share by Technology, 2024
FIG 19 North America Computational Pathology Market share by Technology, 2032
FIG 20 North America Computational Pathology Market by Technology, 2021 - 2032, USD Million
FIG 21 North America Computational Pathology Market share by Country, 2024
FIG 22 North America Computational Pathology Market share by Country, 2032
FIG 23 North America Computational Pathology Market by Country, 2021 - 2032, USD Million
FIG 24 SWOT Analysis: Koninklijke Philips N.V.
FIG 25 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 26 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 27 Recent strategies and developments: PathAI, Inc.
FIG 28 Swot Analysis: PathAI, Inc.
FIG 29 Swot analysis: Hamamatsu Photonics K.K.
FIG 30 SWOT Analysis: Olympus Corporation
FIG 31 Recent strategies and developments: Visiopharm A/S
FIG 32 Swot Analysis: Visiopharm A/S
FIG 33 Swot Analysis: Indica Labs, Inc.

North America Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents